Displaying 3261 - 3280 of 4770
Comentarios de la Comisionada Edith Ramirez, Foro Latinoamericano de Competencia
FTC Announces Agenda for Upcoming Pet Meds Workshop
FTC Staff Makes Recommendations to FERC on Measures to Reduce Cost of Providing Electricity, Improve Power System Reliability
Most-Favored-Nation Clauses and Antitrust Enforcement and Policy
FTC Staff: West Virginia Should Consider Expanding Advance Practice Registered Nurses' Role in Patient Care
FTC Approves Final Order Settling Charges that Novartis AG's Proposed Acquisition of Fougera Holdings, Inc. was Anticompetitive
Novartis AG, In the Matter of (Fougera Holdings, Inc)
The FTC required drug supplier Novartis AG to give up its marketing rights to four topical skin care medications, under a settlement resolving charges that Novartis' acquisition of pharmaceutical firm Fougera Holdings, Inc. would harm competition in the market for these topical drugs. The settlement order requires Novartis to end a marketing agreement that allows it to sell three topically-applied generic drugs and return all rights to a fourth generic drug in development to its manufacturer, Tolmar, Inc. According to the FTC's complaint, Novartis' acquisition of Fougera would violate Section 5 of the FTC Act and Section 7 of the Clayton Act by reducing competition in the generic drug markets for three skin care drugs: 1) generic calcipotriene topical solution, 2) generic lidocaine-prilocaine cream, and 3) generic metronidazole topical gel. The complaint also alleges that the acquisition would eliminate potential competition in the market for the sale of diclofenac sodium gel.
FTC Approves Modified Final Order Settling Charges that CoStar's $860 Million Acquisition of LoopNet was Anticompetitive
CoStar Group, Inc., Lonestar Acquisition Sub, Inc., and LoopNet, Inc., In the Matter of
The FTC required CoStar Group, the largest provider of commercial real estate information services in the United States, to sell LoopNet's ownership interest in Xceligent, under an order settling charges that CoStar's $860 million acquisition of LoopNet would be anticompetitive. The FTC's complaint alleges the proposed acquisition would reduce competition in the markets for real estate listings databases and information services. The modified final order resolving the charges preserves competition that otherwise would have been lost through the acquisition by requiring the combined firm to sell LoopNet's interest in Xceligent, a significant provider of U.S. commercial real estate information.
FTC Closes Its Investigation Into Facebook's Proposed Acquisition of Instagram Photo Sharing Program
Puerto Rican Pharmacy Cooperative Settles Price-Fixing Charges
FTC Submits Brief for the Petitioner with U.S. Supreme Court in Phoebe Putney Hospital Merger Case
Koninklijke Ahold N.V./Safeway Inc., In the Matter of
Koninklijke Ahold N.V., the parent company of Giant Food Stores, LLC, agreed to sell a supermarket outside of Philadelphia, Pennsylvania, to settle charges that its proposed acquisition of the Genuardi's supermarket chain from Safeway Inc. otherwise would be anticompetitive. The transaction, if completed, would eliminate competition between Giant and Genuardi's. To preserve competition in the local grocery market, the consent order requires Ahold to sell a supermarket in Newtown, Pennsylvania to McCaffrey's supermarkets.
FTC Approves Final Order Settling Charges that Koninklijke Ahold's Proposed Acquisition of Genuardi's Supermarkets was Anticompetitive
FTC and Department of Justice to Hold Workshop on "Most-Favored-Nation" Clauses
FTC Files Amicus Brief Explaining That "No-AG" Agreements Are Used by Drug Companies to Delay Generic Competition
FTC Seeks Public Comments on Proposed Amendments to the Premerger Notification Rules Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical Industry
FTC Approves Final Order Settling Charges that Johnson & Johnson's Proposed Acquisition of Synthes, Inc. was Anticompetitive in Market for Treating Traumatic Wrist Injuries
Displaying 3261 - 3280 of 4770